Mizar Therapeutics
Woods Hole, US · Founded 2022 · Delaware corporation
Founders & leadership
PM
Paul MaddoxNamed on SEC filing
JS
Joel SmithNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$518.6K disclosed across 1 round · 2025
▶$518.6KraisedJun 2025 · 6 investors · Other Health CareRule 506(b)
▶$518.6KraisedJun 2025 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul MaddoxExecutive Officer, Director
- Joel SmithExecutive Officer, Director
- Offering amount
- $718.6K
- Amount sold
- $518.6K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Mizar Therapeutics raised?
- Mizar Therapeutics has disclosed $518.6K raised across 1 round.
- Where is Mizar Therapeutics headquartered?
- Mizar Therapeutics is headquartered in Woods Hole, US.